« Previous
Next »
Titles
- Safety and performance based pathway: guidance for industry and Food and Drug Administration1
- Severely debilitating or life-threatening hematologic disorders: nonclinical development of pharmaceuticals1
- Smallpox (variola virus) infection: developing drugs for treatment or prevention1
- Standards development and the use of standards in regulatory submissions reviewed in the Center for Biologics Evaluation and Research1